Background/Aims Age-related macular degeneration (AMD) is the main cause of visual impairment and blindness in Europe. A further increase in the number of affected persons is expected and current ...

Through the program, gene therapies are developed to treat patients with retinitis pigmentosa caused by pathogenic variants ...